These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13867025)

  • 21. [THE BIOLOGICAL SYNDROME OF ARTERIOSCLEROSIS AND ITS CLINICAL VALUE].
    DE BETTENCOURT JM
    J Soc Cienc Med Lisb; 1963 Mar; 127():155-79. PubMed ID: 14113565
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial blood flow and oxygen consumption during postprandial lipemia and heparin-induced lipolysis.
    REGAN TJ; BINAK K; GORDON S; DEFAZIO V; HELLEMS HK
    Circulation; 1961 Jan; 23():55-63. PubMed ID: 13740345
    [No Abstract]   [Full Text] [Related]  

  • 23. Sublingual heparin in hyperlipemia; a preliminary report.
    FULLER HL
    Angiology; 1958 Oct; 9(5):311-3. PubMed ID: 13583625
    [No Abstract]   [Full Text] [Related]  

  • 24. Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit.
    MANGIERI CN; CAIN RA
    Angiology; 1961 Apr; 12():136-8. PubMed ID: 13766149
    [No Abstract]   [Full Text] [Related]  

  • 25. Essential hyperlipemia treated with heparin and with chlorpromazine.
    HOLLISTER LE; KANTER SL
    Gastroenterology; 1955 Dec; 29(6):1069-76. PubMed ID: 13270832
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolysis in relation to lipaemia and intravenous heparin in the white and Bantu.
    LACKNER H; SOUGIN-MIBASHAN R
    S Afr Med J; 1961 May; 35():364. PubMed ID: 13758091
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolonged observations of the cardiovascular status in essential hyperlipemia; with special reference to serum lipid response to heparin.
    SOFFER A; MURRAY M
    Circulation; 1954 Aug; 10(2):255-64. PubMed ID: 13182759
    [No Abstract]   [Full Text] [Related]  

  • 28. [Two cases of xanthomatosis; essential hyperlipemia and familial xanthomatosis; effects of local heparin].
    CARTEAUD A; MAMOU H
    Sem Hop; 1956 Apr; 32(26):1501-4. PubMed ID: 13324269
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipaemia, heparin, and blood viscosity.
    WATSON WC
    Lancet; 1957 Aug; 273(6991):366-8. PubMed ID: 13464069
    [No Abstract]   [Full Text] [Related]  

  • 30. [Post-heparin activity of esterases in human serum. III. Activity following various doses of heparin and effect of alimentary lipemia].
    PAV J; KUHN E; PLACER Z
    Cas Lek Cesk; 1959 Oct; 98():1324-7. PubMed ID: 14431066
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the lipemia clearing and anticoagulant activities of heparin.
    SPITZER JJ
    Am J Physiol; 1954 May; 177(2):337-40. PubMed ID: 13158571
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipemia clearing and anticoagulant effects of small amounts of heparin.
    HARTMANN RC; MENG HC; THORNE CB
    J Appl Physiol; 1955 Mar; 7(5):549-52. PubMed ID: 14367245
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of in vivo heparin on plasma esterase activity and lipaemia clearing.
    LEVY SW; SWANK RL
    J Physiol; 1954 Feb; 123(2):301-14. PubMed ID: 13143512
    [No Abstract]   [Full Text] [Related]  

  • 34. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 35. Properties of heparin-produced lipemia clearing factor.
    SPITZER JJ
    Am J Physiol; 1952 Nov; 171(2):492-8. PubMed ID: 13007822
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of native heparin to clearing of an alimentary lipemia.
    LEVY SW; SWANK RL
    Proc Soc Exp Biol Med; 1953 Apr; 82(4):553-6. PubMed ID: 13055931
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of lipolysis to deturbidification and returbidification in heparin-induced lipemia-clearing phenomenon.
    GROSSMAN MI; STADLER J; CUSHING A; PALM L
    Proc Soc Exp Biol Med; 1955 Jan; 88(1):132-5. PubMed ID: 14357365
    [No Abstract]   [Full Text] [Related]  

  • 38. The clearing by heparin of alimentary lipaemia in coronary artery disease.
    OLIVER MF; BOYD GS
    Clin Sci; 1953; 12(3):293-8. PubMed ID: 13082751
    [No Abstract]   [Full Text] [Related]  

  • 39. EFFECTS OF ACIDIC AZOPROTEINS ON PLASMA TRIGLYCERIDE LEVELS AND ON THE HEPARIN-ACTIVATED CLEARING SYSTEM.
    BROOME JD
    J Exp Med; 1964 Jan; 119(1):83-104. PubMed ID: 14113117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change in the heparin content of the blood in alimentary hyperlipemia].
    JOZSA L; SAJTOS L; PERNECZKY M; BAKOCZAY L; PATAKY J; LUSZTIG G
    Kiserl Orvostud; 1962 Oct; 14():523-6. PubMed ID: 13965028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.